Table 1.
Proteomic study purposes and design choices
Proteomic study purpose | |||
---|---|---|---|
Prediction or classification for clinical utility | Association or classification for biologic insight | Classification for novel subtype discovery | |
Example study | BMD loss or hip fracture[57] | Osteoclast biology[84] | Colorectal cancer subtypes[85, 86] |
Sample source | Human population-at-risk | Human biopsy, animal model, or cell line | Human heterogeneous case mix |
Sample type | Easily accessible, like serum or plasma | Biologically relevant, like bone tissue or osteoblasts | Accessible during diagnosis, like through blood sample or biopsy |
Analytic goal/approach | Portable marker set to optimize prediction or classification | Sufficient marker set to describe biologic process | Portable marker set to optimally separate clinically meaningful classes |
Proteomic technology | Global and targeted | Global | Global and targeted |